R. Durante, A.C.; V. Sobral, D.; C. Miranda, A.C.; V. de Almeida, É.; L. Fuscaldi, L.; R. F. F. de Barboza, M.; Malavolta, L.
Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease. Pharmaceuticals 2019, 12, 25.
https://doi.org/10.3390/ph12010025
AMA Style
R. Durante AC, V. Sobral D, C. Miranda AC, V. de Almeida É, L. Fuscaldi L, R. F. F. de Barboza M, Malavolta L.
Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease. Pharmaceuticals. 2019; 12(1):25.
https://doi.org/10.3390/ph12010025
Chicago/Turabian Style
R. Durante, Ana Claudia, Danielle V. Sobral, Ana Claudia C. Miranda, Érika V. de Almeida, Leonardo L. Fuscaldi, Marycel R. F. F. de Barboza, and Luciana Malavolta.
2019. "Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease" Pharmaceuticals 12, no. 1: 25.
https://doi.org/10.3390/ph12010025
APA Style
R. Durante, A. C., V. Sobral, D., C. Miranda, A. C., V. de Almeida, É., L. Fuscaldi, L., R. F. F. de Barboza, M., & Malavolta, L.
(2019). Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen®, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease. Pharmaceuticals, 12(1), 25.
https://doi.org/10.3390/ph12010025